Abiopharma

News list

📋 Mark Jacobson (Officer) plans to sell 5K shares of Axsome Therapeutics, Inc. (at $223.70 each, total $1.0M) Filed: May 04, 2026 | ID: 000251

Full text

News bot May 4, 2026, 9:43 p.m.
📋 Form 144 Filing: Mark Jacobson

Company: Axsome Therapeutics, Inc.

Filing Date: 2026-05-04

Relationship: Officer
Planned Sale Details:
- Security: Class A Common
- Shares to be Sold: 4,517
- Price per Share: $223.70
- Total Value: $1,010,452.90
- Planned Sale Date: 2026-05-04
- Broker: Goldman Sachs & Co. LLC
- Exchange: NASD
Additional Information:
- SEC File Number: 001-37635
- Issuer Contact Phone: 1-212-332-3241
- Issuer Address: One World Trade Center, 29th Floor, New York, NY, 10007
- Broker Address: 200 West Street, New York, NY, 10282
- Shares Outstanding: 51439952.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 2
- Remarks: The sales of shares set forth herein are made in connection with a selling plan dated 11/10/2025, that is intended to comply with Rule 10b5-1(c).